Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways. - Wikidata - wikimedia - TriplyDB

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

http://www.wikidata.org/entity/Q37727871

about

A Controlled Fermented Samjunghwan Herbal Formula Ameliorates Non-alcoholic Hepatosteatosis in HepG2 Cells and OLETF Rats.

P2860

Q55512003-0177DA56-E2F4-494F-94E4-BD064CDC8524

P2860

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

http://www.wikidata.org/entity/Q37727871

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@en

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@nl

type

label

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@en

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@nl

prefLabel

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@en

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@nl

P1433

Q37727871-038B70B4-9BB0-4D28-8BAD-6D05D2FC0DDD

P1476

Q37727871-D7A7C564-C378-4986-8458-E8B5994FEB81

P2093

Q37727871-0B611501-E060-4C0D-A4FB-0EC98D625C02

Q37727871-3B78D351-D451-449F-9C59-2CB81805B858

Q37727871-6E8DC6A8-97B0-47F4-8C53-AB0A49EB2526

Q37727871-9622D553-42A0-4D5A-9F27-C7A7EFB23759

Q37727871-9A491736-97E6-412A-B27D-5B91FE7C225C

Q37727871-ACC02C97-282D-4B47-BFFE-6BF99C679F56

Q37727871-ADAF81CA-91E9-47FA-BD8F-8BE0652A668C

Q37727871-EAB78919-602C-4D81-A53D-3229AA311A31

Q37727871-F4DA1B55-3AB0-42FF-9A27-908EC7F645CB

P2860

Q37727871-01DF126C-D1E0-4387-9C6E-95659C97B5AE

Q37727871-0DA2C0C3-C7E8-41BF-A8DC-0760F3B4D917

Q37727871-1C93D85B-0A2C-4ADD-994F-9FA8B4F23478

Q37727871-1D079E18-8084-4FF5-A5D9-8E5997B77DB8

Q37727871-1F12D5EE-25AF-43A4-991E-188C4DAEED81

Q37727871-290ED62A-5991-4D8E-89DE-B6D981A2D095

Q37727871-293655BD-1022-4F11-BB35-BFCB3AA82EAE

Q37727871-2B2DD1BD-8C94-442E-A413-F576CC15FC1B

Q37727871-2BADD33A-5124-48DB-A6A4-D298F2ABE243

Q37727871-2E0AF138-5039-4B61-AD4D-CDFB5E4A119F

P2888

Q37727871-6A942CC5-320C-4F89-AC47-2793D30D8AA4

P304

Q37727871-A8A88F02-B842-4D32-A574-597DE84D45A0

P31

Q37727871-6C0173A5-268E-4105-A80A-E5EAB2B189FC

P356

Q37727871-251142BA-A1A4-45ED-BAF0-8CD887E79EC9

P407

Q37727871-FA62DD67-88AA-4E2D-90D0-2CAE486F62F3

P478

Q37727871-099CD9A1-601D-4FE0-974A-5F1514CDC964

P577

Q37727871-E9E33F0C-DBCB-4316-9D3B-38BBA3F69BBD

P698

Q37727871-FAC2AFD0-C44C-4B87-9740-79D425D8033D

P932

Q37727871-600D5770-D080-4A7C-A4C9-8AA3DD1CA288

P356

P1433

Scientific Reports

P1476

Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.

@en

P2093

Dong-Woo Lim

http://www.w3.org/2001/XMLSchema#string

Han Seok Choi

http://www.w3.org/2001/XMLSchema#string

Hojun Kim

http://www.w3.org/2001/XMLSchema#string

Jai-Eun Kim

http://www.w3.org/2001/XMLSchema#string

Jing-Hua Wang

http://www.w3.org/2001/XMLSchema#string

Shambhunath Bose

http://www.w3.org/2001/XMLSchema#string

Song-Hee Jeon

http://www.w3.org/2001/XMLSchema#string

Young-Mi Kim

http://www.w3.org/2001/XMLSchema#string

Young-Won Chin

http://www.w3.org/2001/XMLSchema#string

P2860

Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

A simple method for the isolation and purification of total lipides from animal tissues

Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects

Adipokines, metabolic syndrome and rheumatic diseases

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects

Cholesterol-metabolizing cytochromes P450

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity

AMPK-Dependent Metabolic Regulation by PPAR Agonists.

P2888

P304

45425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP45425

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28358008

http://www.w3.org/2001/XMLSchema#string

P932

5371820

http://www.w3.org/2001/XMLSchema#string